Serum sickness

Serum sickness is a delayed-type hypersensitivity reaction that occurs in response to the administration of foreign serums, vaccines, or antibody-containing preparations. This condition is characterized by manifestations such as fever, rash, arthralgia, and enlarged lymph nodes that occur several days after the administration of the serum. The mechanism of development of this disease involves the formation of a complex of antibodies and antigens, which leads to activation of the immune system and, consequently, to inflammatory reactions in various organs and systems. It is important to note that serum sickness can have serious consequences, including damage to the kidneys, liver, and other organs, which requires careful monitoring and adequate treatment.

History of the disease and interesting historical facts

Serum sickness was first described in the late 19th century, when scientists noticed that the introduction of horse serum for immunization against diphtheria and other infectious diseases could lead to adverse reactions. One of the first studies of this disease was the observation of a patient who was given diphtheria serum, after which he developed a clinical picture consistent with serum sickness. In 1905, scientist M. von Pirquet described the mechanisms of the immune response underlying this disease. Interestingly, serum sickness remains a pressing issue in the field of immunology and allergology to this day, due to the widespread use of serums and biopreparations in medicine.

Epidemiology

Serum sickness is not widespread, but cases of its occurrence are recorded all over the world. According to the World Health Organization, cases of serum sickness are recorded in approximately 1-3% patients receiving serotherapy. The disease is most often observed in individuals receiving serum extracts containing immunoglobulins, as well as in children, especially with an allergic predisposition. Epidemiological studies indicate that the age group of 20-40 years is more susceptible to this disease, probably due to the widespread use of various vaccines and serums.

Genetic predisposition to this disease

It is now established that genetic predisposition plays a role in the development of serum sickness. Genetic studies show that certain polymorphisms in genes that regulate immune responses may increase the risk of developing the disease. For example, changes in genes responsible for the synthesis of interleukins and other cytokines may lead to an excessive allergic reaction to serums. The exact mutations that contribute to the development of serum sickness are still being studied, but research suggests a link between genetic factors and the severity of the disease.

Risk factors for the development of this disease

Risk factors for the development of serum sickness include:

• Previous allergic reactions to serums or similar drugs.
• History of immune system disorders, such as autoimmune diseases.
• Older age, when the immune response may be less predictable.
• Frequent use of serotherapy or vaccines, especially in conditions of low immune status.
• The presence of an allergic history in the patient or his relatives.

Taking these factors into account, the condition of patients receiving therapy with foreign serums should be carefully assessed by a physician to reduce the risk of developing the disease.

Diagnosis of this disease

Diagnosis of serum sickness requires identification of clinical symptoms, analysis of anamnesis and laboratory tests. The main symptoms of the disease include:

• Fever.
• A skin rash typical of allergic reactions.
• Joint pain (arthralgia).
• Enlarged lymph nodes.
• In rare cases, damage to organs such as the kidneys (interstitial nephritis).

Laboratory tests may include a complete blood count, which shows eosinophilia and elevated C-reactive protein, and specific tests for IgE antibodies. Radiographs or ultrasound may show the affected organs if they are involved. Differential diagnosis should include other allergic conditions, infections, or autoimmune diseases.

Treatment

Treatment of serum sickness depends on the severity of the condition and may include both general measures and specific therapy. The main principles of treatment are:

• Complete cessation of administration of the inducing agent (serum).
• Symptomatic treatment aimed at relieving fever and pain using non-steroidal anti-inflammatory drugs.
• Certain cases of severe reactions may require the use of corticosteroids to control the inflammatory response.
• Hospitalization may be necessary in case of severe complications.
• A hypoallergenic diet and treatment of underlying medical conditions may also aid in recovery.

It is important to note that mild forms of the disease can be treated on an outpatient basis and do not require major interventions, while severe forms may require immediate medical attention.

List of medications used to treat this disease

Drugs used to treat serum sickness include:

• Nonsteroidal anti-inflammatory drugs (ibuprofen, naproxen).
• Corticosteroids (prednisolone, methylprednisolone).
• Antihistamines (loratadine, cetirizine).
• Epinephrine for emergency treatment of anaphylaxis.
• Immunosuppressive drugs in severe cases.

The effective choice of therapy depends on the clinical picture and severity of the disease.

Disease monitoring

Monitoring serum sickness involves regular physician visits to assess the patient's progress. Monitoring steps should be regular and include:

• Assessment of symptoms and their severity.
• Laboratory tests to monitor inflammatory markers.
• Ultrasound and other imaging techniques to check the condition of organs.
• Evaluation of the response to treatment.

The prognosis depends on timely diagnosis and initiation of therapy. Possible complications include the development of chronic diseases, kidney damage, and severe allergic reactions. With good medical care, most patients recover without serious long-term consequences.

Age-related features of the disease

Serum sickness may manifest itself differently depending on the age of the patient. In children, the syndrome may be milder, with rapid regression of symptoms after discontinuation of the serum. In the elderly, a more pronounced reaction may be observed, which is associated with age-related changes in the immune system. It is important that physicians take age into account when prescribing serums and vaccinations to minimize the risk of serum sickness.

Questions and Answers

• What is serum sickness?
  Serum sickness is an allergic reaction that occurs in response to the introduction of foreign serums, characterized by symptoms such as fever, rash, and arthralgia.
• How does serum sickness manifest itself?
  Symptoms may include fever, rash, joint pain, and swollen lymph nodes, which usually develop several days after the serum is administered.
• What causes serum sickness?
  The cause is the body's hypersensitivity to antigens contained in the serum, which causes an immune response with the formation of antibodies and inflammatory reactions.
• How is serum sickness treated?
  Treatment includes discontinuation of the offending agent, symptomatic therapy, and in some cases the use of corticosteroids to control the inflammatory response.
• What is the prognosis for serum sickness?
  The prognosis is favorable with timely diagnosis and adequate treatment, but there may be a possibility of developing complications and chronic conditions.

Serum sickness requires a careful diagnostic approach, timely treatment and monitoring of the patient's condition, which emphasizes the importance of medical supervision to prevent serious consequences.